TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/26/24 20:35 | 9/24/24 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Manchester Keith S | X0 | D | S.m | -5,866 | 11.66 | 0 | -503 | -28 | 1,277 | D | |||||||||||||||
8/16/24 16:07 | 8/14/24 | ABUS | Arbutus Biopharma Corp | A1 | Health | Drug | Pharmaceutical Preparations | Manchester Keith S | PA | D | M.d | 31 | 0.5600 | 0 | 55 | 46 | D | ||||||||||||||||
8/16/24 16:07 | 8/14/24 | ABUS | Arbutus Biopharma Corp | A1 | Health | Drug | Pharmaceutical Preparations | Manchester Keith S | PA | D | S.d | -33 | 3.69 | 0 | -9 | -16 | 46 | D | |||||||||||||||
10/2/23 21:05 | 9/28/23 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Manchester Keith S | X0 | D | S | -79,650 | 11.55 | 0 | -6,896 | -8 | 77,610 | I | |||||||||||||||
11/14/22 21:43 | 11/10/22 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Manchester Keith S | X0 | D | S | -18,632 | 4.75 | 0 | -3,923 | -4 | 84,506 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |